Salvatore J Zizza
CIK 929743 · Chief Exectuive Officer · last filed 2026-07-01
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
GCV price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
OLD BETHPAGE, NY 11804
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| GDV | Director | 3,086 | $28.41 | $87.7K | $14.3K | 3 | 2026-07-01 |
| GUT | Director | 13,090 | $5.15 | $67.4K | $99.7K | 10 | 2024-10-25 |
| GGT | Director | 11,037 | $3.35 | $37.0K | $96.7K | 9 | 2024-07-25 |
| GCV | Director | 0 | $3.92 | $0 | $379.2K | 5 | 2023-12-28 |
| GAB | Director | 16,466 | $5.13 | $84.6K | -$8.7K | 8 | 2021-07-23 |
| GGN | Director | 0 | $5.11 | $0 | $196.2K | 5 | 2018-12-31 |
| GRX | Director | 1,165 | $10.00 | $11.7K | $9.5K | 7 | 2018-12-31 |
| GGZ | Director | 150 | $14.70 | $2.2K | $0 | 1 | 2017-12-14 |
| JOB | Chief Exectuive Officer | 9,720 | $0.21 | $2.0K | $30.8K | 9 | 2011-12-23 |
| Harbor BioSciences, Inc. (HEPH) Delisted | Director | — | — | — | $0 | 3 | 2010-02-03 |
Recent Filings · Page 6 of 7
70 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2011-11-16 | JOB | Buy (P) | +29,102 | $8.2K | EDGAR |
| 2011-11-10 | JOB | Buy (P) | +20,000 | $5.9K | EDGAR |
| 2011-10-27 | JOB | Buy (P) | +2,700 | $756 | EDGAR |
| 2011-10-18 | JOB | Buy (P) | +10,000 | $2.7K | EDGAR |
| 2011-09-26 | JOB | Buy (P) | +10,000 | $2.7K | EDGAR |
| 2011-05-11 | GGT | Exer (X) | +389 | $2.7K | EDGAR |
| 2011-05-05 | GGT | Exer (X) | +741 | $5.2K | EDGAR |
| 2011-05-04 | GCV | Buy (P) | +1,000 | $25.2K | EDGAR |
| 2011-04-27 | GRX | Exer (X) | +182 | $1.2K | EDGAR |
| 2011-04-25 | GRX | Exer (X) | +182 | $1.2K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.